MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Recent studies have shown that myocardial ischemia/reperfusion (I/R)-induced necrosis can be controlled by multiple genes.In this study, we observed that both strands (5p and 3p) of miR-223 were remarkably dysregulated in mouse hearts upon I/R.Precursor miR-223 (pre-miR-223) transgenic mouse hearts exhibited better recovery of contractile performance over reperfusion period and lesser degree of myocardial necrosis than wild type hearts upon ex vivo and in vivo myocardial ischemia.Conversely, pre-miR-223 knock-out (KO) mouse hearts displayed opposite effects.Furthermore, we found that the RIP1/ RIP3/MLKL necroptotic pathway and inflammatory response were suppressed in transgenic hearts, whereas they were activated in pre-miR-223 KO hearts upon I/R compared with wild type controls.Accordingly, treatment of pre-miR-223 KO mice with necrostatin-1s, a potent necroptosis inhibitor, significantly decreased I/R-triggered cardiac necroptosis, infarction size, and dysfunction.Mechanistically, we identified two critical cell death receptors, TNFR1 and DR6, as direct targets of miR-223-5p, whereas miR-223-3p directly suppressed the expression of NLRP3 and IB kinase ␣, two important mediators known to be involved in I/R-induced inflammation and cell necroptosis.Our findings indicate that miR-223-5p/-3p duplex works together and cooperatively inhibits I/R-induced cardiac necroptosis at multiple layers.Thus, pre-miR-223 may constitute a new therapeutic agent for the treatment of ischemic heart disease.Reperfusion of ischemic hearts by percutaneous coronary intervention, cardiac surgery, or thrombolytic therapy is commonly used in patients with myocardial infarction (1).However, it is well recognized that reperfusion could induce excessive oxidative stress and inflammation, leading to myocyte death (apoptosis and necrosis) (2).Over the past decades, tremendous efforts have been made to dissect mechanisms under-lying the gene-regulated apoptosis in ischemia/reperfusion (I/R)1 3 -induced cardiac injury, whereas gene-controlled necrosis has received less attention.In recent years, it has become clear that I/R-triggered cardiac necrosis can be regulated by multiple genes/mediators, such as cyclophilin D (CypD), NLRP3, receptor-interacting protein kinase 3 (RIP3) and its partners RIP1, mixed lineage kinase-like (MLKL), and Ca 2ϩcalmodulin-dependent protein kinase (CaMKII) (3-7).Currently, the best characterized form of regulated necrosis (also referred to as necroptosis) is mediated by tumor necrosis factor-␣ (TNF-␣)/TNFR1-induced protein complex RIP1-RIP3 (necrosome) (8).Importantly, several recent studies have demonstrated that inhibition of necroptosis by necrostatin-1, a small molecule capable of suppressing RIP1 kinase activity, alleviated reperfusion injury following acute myocardial infarction in mice, rats, and pigs (9 -12).Nevertheless, given that I/R activates multiple necrosis-associated signals (5, 7, 13), making several necrotic pathways highly intertwined, blocking only one road to cell death may be unlikely to yield the desired outcome in a clinical setting.Therefore, it would be very significant to explore novel strategies aiming to target multiple cell death pathways in I/R hearts.MicroRNAs (miRs; miRNAs), a highly conserved group of small non-protein-coding RNAs, possess the capacity to finetune expression of hundreds of genes (14).Our previous work and that of others have revealed that miRNAs are dysregulated in I/R hearts and actively involved in the modulation of cardiac cell death during I/R (14 -19).Nonetheless, how such miRNAs regulate cell necrosis in I/R hearts remains poorly understood.Along this line, miR-223 has garnered special attention (20).Previously, only the 3Ј-arm of precursor miR-223 (pre-miR-223) (designated as miR-223 or the guide strand) was considered to maturate and become functional, whereas the complementary 5Ј-arm (referred as miR-223* or passenger strand) was destined to be degraded (20).However, we recently discovered that both arms of pre-miR-223 were co-expressed differently in * This work was supported in part by National Institutes of Health Grants HL-087861 and GM-112930 (to G.-C. F.).The authors declare that they have no conflicts of interest with the contents of this article.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Necroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148 · cited 2×
“TNFR1 is well established to bind with the RIP1-RIP3 complex (42, 43), and DR6 has been identified to bind with TRADD (tumor necrosis factor receptor type 1-associated death domain protein), an adaptor of the RIP1-RIP3 complex (32–34).”
BackgroundCaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
Zhang, T., Zhang, Y., Cui, M., Jin, L., Wang, Y., Lv, F., Liu, Y., Zheng, W., Shang, H., Zhang, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4017 · Cited by 790
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
NLRP3 inflammasome activity is negatively controlled by miR-223
Bauernfeind, F., Rieger, A., Schildberg, F. A., Knolle, P. A., Schmid-Burgk, J. L., & Hornung, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201516 · Cited by 544
Regulated cell death and inflammation: an auto-amplification loop causes organ failure
Linkermann, A., Stockwell, B. R., Krautwald, S., & Anders, H.-J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3743 · Cited by 522 · cited 3×
“TNFR1 is well established to bind with the RIP1-RIP3 complex (42, 43), and DR6 has been identified to bind with TRADD (tumor necrosis factor receptor type 1-associated death domain protein), an adaptor of the RIP1-RIP3 complex (32–34).”
BackgroundTakahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J. B., Goossens, V, Roelandt, R., Van Hauwermeiren, F., Libert, C., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.176 · Cited by 465
Cited by
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 961
Zhang, Y., Liu, X., Bai, X., Lin, Y., Li, Z., Fu, J., Li, M., Zhao, T., Yang, H., Xu, R., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12449 · Cited by 399
Mitra, R., Adams, C. M., Jiang, W., Greenawalt, E., & Eischen, C. M. (2020) · Nature Communications · doi:10.1038/s41467-020-14713-2 · Cited by 81
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
“The beneficial miR-223 inhibits the receptors TNFR1 and DR6, thereby preventing necroptosis; whereas the harmful miR-103/107 inhibits the antinecrotic receptor Fas-associated death domain protein, thereby activating necroptosis (54, 55).”
BackgroundWang, Y., Jiao, J., Ren, P., & Wu, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28438 · Cited by 24
Metadata
- Authors
- Qin, D., Wang, X., Li, Y., Yang, L., Wang, R., Peng, J., Essandoh, K., Mu, X., Peng, T., Han, Q., Yu, K.-J., & Fan, G.-C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 291
- Issue
- 38
- Pages
- 20247-20259
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2481564434
- Cited by
- 134
- References
- 6
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts. https://app.cochat.ai/papers/10.1074/jbc.m116.732735
- The paper
- Qin, D., Wang, X., Li, Y., Yang, L., Wang, R., Peng, J., Essandoh, K., Mu, X., Peng, T., Han, Q., Yu, K.-J., & Fan, G.-C. (2016). MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m116.732735
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.